Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
12-month phase IV study of Clonid-Ophtal versus Tim-Ophtal in ocular hypertension or open-angle glaucoma
2005-001976-12Phase 4Completed
- Sponsor
- Dr. Winzer Pharma
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of clonidine and timolol in ocular hypertension and open-angle glaucoma (OAG) (2 arms), sponsored by Dr. Winzer Pharma. Primary endpoint: Local and systemic tolerability. Started Jun 2005; status: completed.
02
Drugs
clonidinetimolol
03
Conditions
ocular hypertensionopen-angle glaucoma (OAG)
Beyond the preview
Go deeper on 2005-001976-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001976-12.